COMPANY PROFILE

Radar Therapeutics

Ribonucleic acid sensing technology for therapies that identify and eliminate pathogenic cells based on their genetic activity

Berkeley, United StatesFounded 2022Biotech & Life Sciences

Valuation $50–100M Last recorded · 2024

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Radar Therapeutics

Radar Therapeutics is a biotechnology company that develops programmable precision therapeutics. The company's technology is based on ribonucleic acid (RNA) sensing, which allows for the creation of therapies that can identify and target pathogenic cells based on their specific transcriptional signatures or genetic activity. This approach utilizes messenger RNA (mRNA) to create smart programmable medicines.

The company, founded in 2022, recently secured $13.4 million in an oversubscribed seed financing round. This funding is intended to advance the development of its platform and pipeline of therapeutic candidates. The technology has the potential to address a wide range of diseases by precisely targeting unhealthy cells while leaving healthy ones untouched. The business model likely involves partnerships or licensing agreements with larger pharmaceutical firms to bring these treatments through clinical trials and to the market.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Berkeley, United States
Employees: 17
Open positions: None listed
Dealroom signal: 68.6/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Technology: Autonomous & Sensor Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	May 2024	$13M	$54M	Pear Ventures · Eli Lilly · NFX · KdT Ventures	↗
GRANTOther financing	May 2023	$0	—	Pear Ventures	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Radar Therapeutics website traffic

Latest recorded traffic for Radar Therapeutics is 2.2K monthly website visits, down 18.5% over the last three months. Radar Therapeutics's team grew 13.3% over the past year.

Latest monthly visits2.2K 3-month web change-18.5% 1-year team growth+13.3%

Monthly website visitsMay 2024–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HOHolloidProvides real-time multi-dimensional data on colloids, based on 3D imaging, with the throughput of cytometry	Vienna, Austria	Operational	15	$4.7M	$8.8M
FBFOx BiosystemsFox biosystems produces fiber-optic biosensor instruments	Diepenbeek, Belgium	Operational
ARArgusEyeReal-time, in-line sensor systems for biopharmaceutical manufacturing	Linköpings kommun, Sweden	Operational
KIKimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors	Paris, France	Operational
ABAureka BiotechnologiesAI-native platform for immunotherapeutic drug discovery.	Laguna Hills, United States	Operational
PBPhiTech BioinformaticsUsing advanced algorithms for diagnostic decision making in the areas of life and environmental sciences, and biotechnology	Gebze, Türkiye	Operational
MOMoleculeMindA leading AI protein design platform company	Haidian, China	Operational
ARArontierInnovative AI-driven solutions targeting cancer treatment through precision medicine and anti-CAF drug development	Seoul, South Korea	Operational